We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low-Calorie Cranberry Juice Shown to Lower Cardiovascular Disease Risk

By LabMedica International staff writers
Posted on 14 Jul 2015
Supplementing the diet with low-calorie cranberry juice (LCCJ) reduces the chances of developing cardiovascular disease by lowering several risk factors including circulating triglycerides (TGs), C-reactive protein (CRP), glucose, and diastolic blood pressure (BP).

Investigators at the United States Department of Agriculture (Beltsville, MD, USA) and Ocean Spray Cranberries, Inc. More...
(Lakeville-Middleborough, MA, USA) conducted a double-blind, placebo-controlled, parallel-arm study on 30 women and 26 men. For eight weeks the participants ate controlled diets supplemented with twice daily drinks of 240 milliters of LCCJ or a placebo beverage, containing 173 or 62 mg of phenolic compounds and 6.5 or 7.5 g of total sugar per 240 milliliter serving, respectively.

Results published in the April 22, 2015, online edition of the Journal of Nutrition revealed that fasting serum TGs were lower after consuming LCCJ and that the participants with higher baseline TG concentrations were more likely to experience a larger treatment effect. Other cardiovascular disease risk factors including serum C-reactive protein (CRP), diastolic blood pressure (BP), and fasting plasma glucose were lower for individuals consuming LCCJ than for individuals consuming the placebo beverage. Furthermore, LCCJ had a beneficial effect on homeostasis model assessment of insulin resistance for participants with high baseline values.

"At the start and end of the experiment, the researchers measured things like blood pressure, blood sugar levels, blood lipids, as well as C-reactive protein, a marker of inflammation," said contributing author Dr. Christina Khoo, director of research sciences at Ocean Spray Cranberries, Inc. "All of these measurements come together to tell a story. The worse off these numbers are in an individual, the more likely he or she will face a health condition like diabetes, heart disease, or stroke in the future. These findings suggest that polyphenols help to protect our bodies, and may be adept at keeping a large number of ailments at bay. Luckily for us, a rich source of polyphenols is only a glass of cranberry juice away. Among the commonly consumed fruits in our diets, cranberries boast some of the highest levels of polyphenols—more than apples, blueberries, grapes, or cherries."

The investigators suggested that individuals drinking two glasses of LCCJ per day could experience up to a 10% percent lower risk of heart disease and a 15% percent lower risk of stroke.

Related Links:

United States Department of Agriculture
Ocean Spray Cranberries, Inc. 



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.